The PeriFlux 6000 is the latest generation transcutaneous oxygen and carbon dioxide monitoring equipment from Perimed. Small and portable, the PeriFlux 6000 is operated using a touchscreen interface. Remote panel systems are available to facilitate use in hyperbaric chambers. The PeriFlux 6000 is HIPAA compliant.
The PeriFlux 6000 consists of a main unit which can be equipped with up to 8 channels of tcpO2/tcpCO2. Each channel is used together with one Clark type electrode (for tcpO2 only) or one combined pO2/pCO2 sensor (for tcpO2/tcpCO2).
Step-by-step instructions guide the user throughout the procedure. Several test may be implemented adapting the workflow to different clinical examinations. It is also possible to extend a baseline measurement with a provocation such as an oxygen challenge (tcpO2 measurement during 100 % oxygen inhalation), whenever necessary.
For best data interpretation it is important to view tcpO2 data in relation to the wound. Documentation of wounds with photos is already standard at many hospitals. A photo of the wound can be incorporated directly into the report by connecting a digital camera to the instrument. The SITE section in the PeriFlux 6000 software makes it possible to indicate each tcpO2 site directly in the photo and to assure correct color coding and naming.
A comprehensive report summarizing all the results, including exact site positioning documentation, is printed or exported as a PDF file when the examination is completed. The report template can be customized according to the requirements of the user.
The PeriFlux 6000 operates as a standalone system but may also be connected to a PC. The PC module software – PeriFlux Configuration Software (PCS) – is used to transfer data from the instrument to a PC. In PCS data can be reviewed and edited. PCS is also used for defining test and report templates
As part of the PeriFlux product family, the PeriFlux 6000 tcpO2 can be completed with additional functionality. Add laser Doppler and pressure to extend your vascular evaluation with a toe pressure and ankle-brachial index (ABI).
Why measure tcpO2?
Peripheral Arterial Disease (PAD) and microvascular impairment will influence the outcome of a wound. To prevent limb loss, the degree of ischemia has to be assessed early. Transcutaneous oxygen (tcpO2) has proven to be a useful tool to predict wound healing potential. tcpO2 is particularly important in patients with critical limb ischemia and/or diabetes, as these patients commonly have impaired microvascular function and falsely elevated ABI values.
Watch Dr Fife discussing the clinical uses of tcpO2 by watching the video.
Manufactured by Perimed AB, Sweden